# Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls

> **NCT00448799** · PHASE1 · COMPLETED · sponsor: **Molecular NeuroImaging** · enrollment: 30 (estimated)

## Conditions studied

- Alzheimers Disease

## Interventions

- **RADIATION:** [123-I] AV-83 Injection and Imaging Procedures

## Key facts

- **NCT ID:** NCT00448799
- **Lead sponsor:** Molecular NeuroImaging
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00448799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00448799, "Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00448799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*